Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide injection pens function as glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications originally developed for type 2 diabetes that now dominates weight loss therapy. Clinical trials show semaglutide users lose 15–22% of body weight over 68 weeks when combined with lifestyle changes. PlexusDx delivers compounded semaglutide from licensed 503A pharmacies across all 50 states, with pricing that stays flat regardless of your dose level.
The GLP-1 Hormone and Your Appetite Control System
Your intestines naturally release GLP-1 hormones when you eat, signaling your brain that you are full and slowing the rate food leaves your stomach. Semaglutide mimics this hormone by binding to GLP-1 receptors throughout your central nervous system and digestive tract. This activation triggers three simultaneous changes: reduced hunger signals in the brain, increased feelings of fullness from smaller meals, and slower gastric emptying that keeps you satisfied longer between eating occasions.
Unlike simple calorie restriction, which often fails because your body adapts by increasing hunger hormones, semaglutide works with your body's natural satiety system. Research from the New England Journal of Medicine demonstrated that GLP-1 agonists reduce appetite independent of calorie intake, meaning weight loss occurs not from willpower but from genuine biochemical shifts in how your brain processes food motivation.
How Semaglutide Injection Dosing Works Over Time
Semaglutide pens deliver medication weekly via subcutaneous injection, typically in the thigh, abdomen, or upper arm. Treatment begins at 0.25 mg weekly, with doses increasing incrementally every four weeks—0.5 mg, 1.0 mg, 1.7 mg, and finally 2.4 mg—based on your tolerance and response. This gradual titration strategy minimizes nausea and allows your body to adapt to the medication's effects, improving both safety and adherence rates.
PlexusDx customizes your titration schedule based on your individual response profile and, optionally, your genetic predispositions via the Precision Peptide Genetic Test. Your dose may need to go up; your price will not—PlexusDx charges a flat monthly rate starting at $149, regardless of whether you remain at 0.5 mg or advance to the full 2.4 mg maintenance dose.
Weight Loss Results and Timeline with Semaglutide Injections
Most patients experience measurable appetite reduction within the first two weeks of starting semaglutide, though weight loss becomes noticeable after four to eight weeks as caloric intake naturally decreases. Landmark clinical trials—the STEP program—enrolled over 4,500 adults with obesity and found those receiving semaglutide 2.4 mg weekly lost an average of 10.2 kg (22.5 lbs) by week 16, with losses continuing through week 68. Importantly, weight regain occurs gradually if semaglutide is discontinued, reinforcing that it addresses the chronic biological drive to overeat rather than serving as a temporary fix.
Individual results vary based on baseline metabolism, adherence to the injection schedule, dietary patterns, and genetic factors. PlexusDx's Precision Peptide Genetic Test examines key variants in the GLP1R (rs6923761), GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) genes to predict your likely response magnitude and identify which pathway—GLP-1, glucose-dependent insulinotropic peptide (GIP), or dual activation—may optimize your outcome.
Managing Side Effects and Maintaining Long-Term Success
Nausea is the most common side effect of semaglutide, reported in 25–40% of patients during dose escalation, but typically resolves within days to weeks as the body acclimates. Slower titration schedules, smaller meals, and avoiding high-fat foods reduce gastrointestinal symptoms significantly. Other possible effects include constipation, vomiting, and diarrhea; these are generally mild to moderate, dose-dependent, and reversible upon dose reduction or discontinuation.
Long-term success with semaglutide depends on sustained use, regular physical activity, and eating patterns that align with the medication's appetite-suppressing effects. PlexusDx patients receive ongoing dose management support and can add the Precision Peptide Genetic Test ($99 after the first month) to refine treatment strategy based on your unique peptide-pathway biology. HSA and FSA accounts cover compounded semaglutide, making therapy accessible regardless of insurance status across all 50 states.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
How quickly will I lose weight on semaglutide injections?
Most patients see appetite reduction within 1–2 weeks and measurable weight loss between 4–8 weeks. The STEP trials showed average losses of 10+ kg by week 16 with continued decline through week 68. Individual pace depends on your starting weight, metabolic rate, and adherence to the weekly injection and dietary changes.
What is the difference between semaglutide and tirzepatide?
Semaglutide activates only GLP-1 receptors, while tirzepatide (PlexusDx Compounded Tirzepatide, starting at $249/mo) activates both GLP-1 and GIP receptors simultaneously. Some patients respond better to dual activation, while others achieve excellent results with GLP-1 alone. PlexusDx Precision Peptide Genetic Testing helps identify which pathway matches your biology.
How much does PlexusDx compounded semaglutide cost?
PlexusDx Compounded Semaglutide Injection starts at $149/month and remains that flat rate regardless of dose level—your dose may go up, your price will not. The medication comes from licensed 503A compounding pharmacies, requires no insurance, and is HSA/FSA eligible across all 50 states.
Are there serious safety concerns with semaglutide?
Semaglutide is generally well-tolerated, with nausea being the most common side effect—usually mild and temporary. Rare risks include pancreatitis, gallbladder disease, and thyroid concerns; discuss your medical history with PlexusDx clinicians before starting. The medication should not be used in pregnant individuals or those with personal or family history of medullary thyroid cancer.
Can genetic testing help predict my semaglutide response?
Yes. PlexusDx Precision Peptide Genetic Test ($99 add-on after first month) analyzes variants in GLP1R, GIPR, FTO, and MC4R genes across 14 metabolic pathways to predict your likely weight loss magnitude and optimal compound choice. This personalization helps clinicians adjust your dosing strategy and decide whether semaglutide or a dual-compound option may work better for your biology.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Ozempic and Blood Clots: Essential Considerations for Your Health Journey
Mounjaro Pens: Are All Strengths and Designs the Same? Navigating Your Weight Loss Journey